BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Acerus Acquires Canadian Rights to Novel Pain Relief Product for Gynecological Procedures from Pharmanest

  Acerus Pharmaceuticals Corporation today announced that it has entered into an exclusive agreement to commercialize Pharmanest AB (“Pharmanest”) Short Acting Lidocaine product (“SHACT”), a novel pain relief drug device combination in Canada.

  May 29, 2018

   · 

  7 min read
• Second OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy Held in Shanghai, Promoting Precision Medicine of China to Go Global

  On May 26, 2018, the Second OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy was held in Shanghai. Themed on “Broader Vision, Deeper Insight”.

  May 29, 2018

   · 

  6 min read
• Biotech Beach

  Rigel Announces Availability of TAVALISSE™ (fostamatinib disodium hexahydrate) in the U.S.

  Rigel Pharmaceuticals, Inc. announced that TAVALISSE™ (fostamatinib disodium hexahydrate) is available by prescription for the treatment of thrombocytopenia in adult patients.

  May 29, 2018

   · 

  7 min read
• BioMidwest

  Health Catalyst One of Inc. Magazine’s Best Workplaces 2018

  Health Catalys has been named one of Inc. magazine’s Best Workplaces for 2018.

  May 29, 2018

   · 

  2 min read
• FDA

  U.S. FDA Grants Priority Review to Astellas’ New Drug Application for Gilteritinib for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

  FLT3 mutations impact approximately 30 percent of AML patients and are often associated with poor survival outcomes.

  May 29, 2018

   · 

  6 min read
• Policy

  Volumes Achieved as Haiti’s ‘Change Caravan’ Marks Its First Year

  In the one year since Haiti’s President Jovenel Moïse launched his flagship ‘Change Caravan’ initiative, the country has experienced significant improvements across several areas.

  May 29, 2018

   · 

  3 min read
• Biotech Bay

  Invokana: The Diabetic Drug That Costs a Limb

  29 million people have type 2 diabetes in the U.S. making it big business for pharmaceutical companies.

  May 29, 2018

   · 

  2 min read
• Biotech Beach

  Kush Bottles CEO Nick Kovacevich to Speak at Cannabis World Congress & Business Exposition in New York City

  Kush Bottles, Inc. announced that CEO Nick Kovacevich will be participating on several panels at the Cannabis World Congress & Business Exposition (CWCBExpo) being held this week at the Javits Center in New York City.

  May 29, 2018

   · 

  5 min read
• Isolation and Recombinant Expression of Key Enzyme for Opioid Production

  Intrexon Corporation announced the isolation and recombinant expression of a novel gene from the opium poppy (Papaver somniferum) encoding the enzyme, thebaine synthase.

  May 29, 2018

   · 

  5 min read
• Pharm Country

  Cannabis and CBD Markets are Set to Increase in Value

  According to a report by Hexa Research, the U.S. medical cannabis market is projected to reach $19.48 billion by 2024.

  May 29, 2018

   · 

  10 min read